News

SA biotech buys Birmingham company

CytoBioscience CEO James Garvin said the acquisition of BioDtech is a big win for his San Antonio-based ...

SA biotech CEO: Company on the verge of taking cancer-detection product to market

Seno Medical Instruments Inc. CEO Tom Umbel said the company is picking up momentum. GABE HERNANDEZ | ...

Events

BioMed SA Annual Breakfast Meeting

When: 7:30-9:30 AM Tuesday, December 18, 2018 Where: Omni Hotel, 9821 Colonnade Blvd. Join ...
Stakeholders - Bioscience Firms
Viewing 32 results
 
 from: Bioscience Firms

Bioscience Firms (31)

Acelity is a globally diversified wound care and regenerative medicine company that unites the strengths of the three heritage companies Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Acelity is headquartered in San Antonio, Texas, with a team of more than 5,800 employees around the world.

The mission of Astrocyte Pharmaceuticals – a Cambridge, MA-based company built around research from the UT Health Science Center at San Antonio - is to develop a breakthrough neuroprotective therapeutic that activates the inherent caretaker mechanisms of astrocytes to treat brain injuries.

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. Founded in 1897, BD employs over 27,000 people worldwide and serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

bioAffinity Technologies addresses a critical need to find cancer early and treat cancer specifically by developing tests and therapies to detect and treat cancer at the cellular level.  CyPath® Lung, bioAffinity Technologies’ first product, is being developed for the detection of early-stage lung cancer.

Biomedical Development Corporation is commercializing a portfolio of pharmaceuticals that decrease bacterial bioburden in the mouth, reduce chronic inflammation, and subsequently improve systemic health. Biomedical Development Corporation has two drugs in Phase 2 clinical trials.

BME’s business initiatives as a medical device manufacturer and research service provider have allowed it to increase the medical community’s knowledge in osteoporosis, bone healing, and bone replacement materials. BME's strategy is focused on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response.

Cancer Insight is a clinical research organization in the area of cancer immunotherapy.  Through its subsidiary, CI is also discovering and developing innovative cancer immunotherapies.

CellRight Technologies LLC is a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteobiologic and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease.

CeloNova BioSciences is a pioneer in cardiovascular innovation. Leveraging its novel Polyzene-F core technology, CeloNova is transforming the treatment of cardiovascular disease and promoting positive outcomes in patients around the world. The proprietary COBRA PzF NanoCoated Coronary Stent System is the latest generation stent featuring the nano-thin Polyzene-F nanocoated surface modification.

CHS is a subsidiary of Chenega Corporation, which provides oversight and “back office” administrative support to its subsidiaries to assist in contract performance. This structure provides significant financial and resource reach-back, and streamlines internal processes enabling greater flexibility for the customer. All Chenega Corporation-managed subsidiaries are able to perform responsively, agilely, and effectively as small businesses with the strong financial backbone of Chenega Corporation.

 

CytoBioscience is a world leader in high-throughput, high-accuracy cellular patch clamp testing - a method for measuring microscopic voltage changes caused by the movement of molecules through the membrane ion channels of a cell, a function that is central to cellular physiology and drug-cell interactions. CytoBioscience is opening up new avenues of research in drug development, neuroscience, diabetes, and personalized medicine.

Dominion Aesthetic Technologies, Inc., is a Texas based corporation focused on the commercialization of medical devices in the aesthetic field. The aesthetic market is rapidly expanding based upon consumer/patient demand and the continued improvement and availability of non-invasive alternatives to surgical procedures.

A contract development and manufacturing organization (CDMO) offering full service sourcing solutions for the world’s leading pharmaceutical, biotechnology and healthcare companies.

Electrochemical Oxygen Concepts, Inc. (EO2 Concepts™) is an innovative wound care company based in San Antonio, TX. Its first product, the TransCu O2™ device, is a unique, non-invasive, electrochemical tissue oxygenation system intended for use with lower-cost moist wound dressings for the treatment of diabetic foot ulcers, venous leg ulcers, pressure ulcers and other skin wounds through the continuous diffusion of oxygen.

Evestra seeks to improve the health and wellness of women around the world through innovative technologies and commercially viable products focused primarily on fertility control, gynecological disorders and oncology.

INCELL is a recognized human stem cell therapy company, and FDA-registered manufacturer and biobank cryostorage facility. INCELL manufactures products for itself and its clients, and provides contract services in product development, pre-clinical testing, personalized medicine and clinical trials in the areas of regenerative medicine, cancer, vaccines and infectious diseases.

iTraumaCare™ is addressing unmet needs in the field of emergency medicine by developing, manufacturing, and commercializing point of injury solutions to treat common causes of preventable death in traumatic injury scenarios. 

Luminus Biosciences has created a groundbreaking drug delivery platform using lipid drug nanospheres stabilized by protein to formulate poorly water soluble molecules. The formulation is less toxic and the nanospheres carry the drugs directly to the cells resulting in improved efficacy. Luminus Biosciences supports research and development of drug molecules for treatment of cancer, epilepsy, first-degree burns, pain management and ophthalmic ailments.

 

 Medical Care Innovations is the parent company of EndoMune Advanced Probiotic, the only GI-developed probiotic on the market for adult and children.

At Medtronic, Innovating for life means we’re committed to finding more ways to help more people around the world. Constantly pushing the limits of medical technology. Driven by our deep understanding of the human body and our collaboration with physicians, we're transforming technology to treat patients across the entire care continuum. Our innovations help physicians diagnose diseases earlier, treat patients with the least amount of disruption possible, and help alleviate symptoms throughout the patient's life.

Metric Medical Devices is focused on developing internal bone fixation implants for the hand, wrist, foot & ankle that speed healing and minimize non-healing by pulling together and compressing bone.

For more than sixty years, privately held Mission Pharmacal has been dedicated to identifying unmet health needs and developing innovative products to meet them.

NuPak provides a broad array of development, prototypes, testing, injection molding and packaging services for the entrepreneur, inventor, and large medical corporations. We specialize in contract medical manufacturing.

Progenerative Medical is translating clinically-proven Reduced Pressure Therapy to orthopedic indications.

Prytime Medical is an innovative medical device company that designs, develops and commercializes minimally invasive solutions for vascular trauma. The company’s flagship product is the ER-REBOA™ Catheter, designed specifically for rapid, temporary occlusion of large vessels in the emergency and critical care environment during REBOA (Resuscitative Endovascular Occlusion of the Aorta) procedure. The underlying intellectual property for the ER-REBOA™ Catheter was conceived by experienced military vascular and trauma surgeons based lessons learned on the battlefield.

QualTex Laboratories performs testing services for clients that collect, prepare, and distribute FDA regulated blood components/biological products for human therapies. Tests performed are used to qualify blood/plasma donors and support global public safety.

Rochal Industries is a privately owned bioscience company focusing on the development of new polymeric materials for wound and burn care treatment.  Rochal licenses its intellectual property to companies capable of commercializing the resulting products.

Santalis Pharmaceuticals is on the leading edge of developing a unique platform of highly differentiated prescription and over-the-counter healthcare products based on its sustainably-grown pharmaceutical-grade East Indian Sandalwood Oil (EISO), also known as Sandalwood Album Oil (SAO).

Seno Medical Instruments Inc. is focused on the early detection of cancer through the use of its patented opto-acoustic imaging technology.

StemBioSys manufactures and develops novel, proprietary stem cell technologies to meet the promise of regenerative medicine in a surging global market. Housed in San Antonio, StemBioSys is led by an experienced management and scientific team.

Xenex was founded to significantly reduce the number of healthcare associated infections that destroy the lives of millions of patients and their families by perfecting and monitoring the use of pulsed xenon UV (PX-UV) disinfection to decontaminate patient care environments.

Stay informed. Subscribe to BioMed SA news alerts.